Mark Gilchrist

The #Adelaide ID nerds runners club 😊

#Antimicrobials2026 #IDSky
@steventong.bsky.social @benrogersedu.bsky.social @mgilchrist123.bsky.social @ausantibiotics.bsky.social

Plenary 1 is underway at #Antimicrobials2026: AMS in the Home.
As care increasingly shifts beyond hospital walls, stewardship must follow. Governance, oversight and patient safety don’t stop at discharge, they evolve.

#AMS #AMR #InfectiousDiseases #OPAT #HITH #Idsky #medsky #ASA

Exploring the opportunity for therapeutic drug monitoring (TDM) and precision dose antimicrobials in an outpatient antimicrobial therapy (OPAT) service: a prospective observational study AbstractObjectives. Notwithstanding the wide uptake of outpatient antimicrobial therapy (OPAT) in the UK, there is a paucity of data on antimicrobial expos

🩺🦠How well do #OPAT antimicrobials really hit PK-PD targets? Our UK prospective study shows good attainment across agents, while demonstrating the feasibility of #TDM to support #precisiondosing in outpatient infection care doi.org/10.1093/jac/... @tmrawson.bsky.social @mgilchrist123.bsky.social

Operational considerations for the running of an NHS faecal microbiota transplant (FMT) service

www.sciencedirect.com/science/arti... - we used an AMS approach to operationalise & formalise a structured approach to FMT @imperialcollegeldn.bsky.social @imperialnhs.bsky.social

Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey AbstractObjectives. This study aimed to assess the current international practices of outpatient parenteral antimicrobial therapy (OPAT).Methods. A multi-s

Current practices in OPAT programmes: 🌍 multi-centre survey - variation exists - need to understand differences to drive improvement @raseaton66.bsky.social @bsacandjac.bsky.social @conorjamieson.bsky.social academic.oup.com/jacamr/artic...

Stability of tigecycline in elastomeric devices for OPAT - Tigecycline meets the 🇬🇧 YCD criteria of ≤5% degradation limit. Fantastic collaboration with 🌍 colleagues @bsacandjac.bsky.social @raseaton66.bsky.social academic.oup.com/jacamr/artic...

Outpatient parenteral antimicrobial therapy significantly reduces cost of antimicrobial therapy compared to treatment in a hospital bed:
doi.org/10.1093/jaca...
@mgilchrist123.bsky.social @bsacandjac.bsky.social #JACAMRNews #OPAT #IDSky

@erinmccreary.bsky.social @mmpharmd.bsky.social

Delighted to spend time talking (inter)national (C)OPAT strategies with @raseaton66.bsky.social @bsacandjac.bsky.social in my home town - workshops, conferences, working with new friends at SIDP, new GPRs coming, stability with Oz partners, opportunities, new connections-it will be an exciting year!

Call for Global Standards in Antimicrobial Stability Testing to Improve Outpatient Care - The British Society for Antimicrobial Chemotherapy

‘By standardising stability testing guidelines, we can broaden treatment options for patients with serious infections, improve clinical outcomes, advance antimicrobial stewardship, and reduce healthcare costs.’ @jac-amr.bsky.social @raseaton66.bsky.social @mgilchrist123.bsky.social

Check it out! BSAC's OPAT Conference 2024 has been featured on the ID:IOTS Podcast @idiots-pod.bsky.social! You can find the episode on Spotify - episode notes here: idiots.notion.site/94-BSAC-OPAT... @raseaton66.bsky.social

A quick reminder that the BSAC Winter Conference begins next week, 4-5 December! If you haven't booked your place yet, there's still time bsac.org.uk/infection2024/

🔥SNAP passed 3500🔥
Writing papers:
Cefazolin (MSSA) and penicillin (PSSA) vs (flu)clox
Recruiting:
Adj clinda vs not (all)
Adj cefazolin vs not (MRSA)
Oral switch vs IV (all)
Cefazolin +/- Erta/Placebo (MSSA)
Dapto vs Vanco (MRSA)
Coming "soon":
Rifampin vs. none for PVIE (all)
Ref: Dr.Lee #idsky

Is it time for global harmonization of OPAT drug stability testing frameworks? Great to collaborate with global colleagues from Australia and UK - still work to be done!